High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
Authors:
- Mirko ScordioMSMirko Scordio
- Federica FrascaFFFederica Frasca
- Letizia SantinelliLetizia Santinelli
- Leonardo SorrentinoLSLeonardo Sorrentino
- Alessandra PierangeliAPAlessandra Pierangeli
- Ombretta TurrizianiOTOmbretta Turriziani
- Claudio M. MastroianniCMClaudio M. Mastroianni
- Guido AntonelliGAGuido Antonelli
- Raphael P. ViscidiRVRaphael P. Viscidi
- Gabriella D'ETtorreGabriella D'ETtorre
- Carolina ScagnolariCSCarolina Scagnolari
- 25 June 2022
- journal article
- letter
- Published by Elsevier in Clinical Immunology
- Vol. 241, 109068
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
This publication has 16 references indexed in Scilit:
- COVID-19 Severity Index: A predictive score for hospitalized patientsMedicina Intensiva (English Edition), 2022
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsScience Immunology, 2021
- Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 PandemicsThe Journal of Infectious Diseases, 2021
- Differentially expressed immune response genes in COVID-19 patients based on disease severityAging, 2021
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Science, 2020
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19Science, 2020
- Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1Frontiers in Immunology, 2018
- Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiomeCytokine & Growth Factor Reviews, 2018
- ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell responseImmunobiology, 2016
- Absence of Clinical, Virological, and Immunological Signs of Progression in HIV-1-Infected Patients Receiving Active Anti-Interferon-α Immunization: A 30-Month Follow-Up ReportJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996